Gastric tube cancer after radical esophagectomy: comparison of two periods in a single center
Tóm tắt
Recent improvements in the survival of patients after esophagectomy have led to an increasing occurrence of gastric cancer in the reconstructed gastric tube (GTC). The aim of this study was to assess generational changes in the clinicopathological
characteristics and treatment of GTCs in a single center. Thirteen GTC lesions in ten patients were diagnosed and treated at Keio University Hospital between 2006 and 2014. In our previous study, we reported eight cases of GTC [1]. We compared clinicopathological characteristics and treatment of GTC, as well as overall survival achieved in this study with those in our previous study [1]. In this study, median patient age at the time of GTC detection was 74 years (range 62–81 years) and the median interval between esophagectomy and GTC detection was 95 months (range 21–159 months). Nine (69 %) of 13 lesions satisfied the criteria for endoscopic resection. On comparing this study with our previous study, there were no significant differences in patient age at the time of GTC detection, the interval between esophagectomy and GTC detection, or pathological stage [1]. Compared with our previous study, the use of less invasive treatments, such as endoscopic submucosal dissection and partial gastric tube resection with sentinel lymph node dissection, generationally increased and a significant difference was observed in the type of GTC treatment [1]. However, there was no significant difference in overall survival between the studies. Long-term periodic endoscopy permits less invasive treatments and combinations of various treatments for effective GTC therapy.
Tài liệu tham khảo
Okamoto N, Ozawa S, Kitagawa Y, et al. Metachronous gastric carcinoma from a gastric tube after radical surgery for esophageal carcinoma. Ann Thorac Surg. 2004;77:1189–92.
Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol. 2003;21:4592–6.
Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.
Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727–33.
Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062–7.
Nonaka S, Oda I, Sato C, et al. Endoscopic submucosal dissection for gastric tube cancer after esophagectomy. Gastrointest Endosc. 2014;79:260–70.
Sugiura T, Kato H, Tachimori Y, et al. Second primary carcinoma in the gastric tube constructed as an esophageal substitute after esophagectomy. J Am Coll Surg. 2002;194:578–83.
Tawaraya S, Jin M, Matsuhashi T, et al. Advanced feasibility of endoscopic submucosal dissection for the treatment of gastric tube cancer after esophagectomy. Gastrointest Endosc. 2014;79:525–30.
Bamba T, Kosugi S, Takeuchi M, et al. Surveillance and treatment for second primary cancer in the gastric tube after radical esophagectomy. Surg Endosc. 2010;24:1310–7.
Sobin LH, Wittekind C. TNM Classification of Malignant Tumors, 6th ed. New York:Wiley; 2002.
Association Japanese Gastric Cancer. Japanese Classification of Gastric Carcinoma. 2nd English Ed. Gastric Cancer. 1998;1:10–24.
Society JE. Japanese classification of esophageal cancer. 10th ed. Tokyo: Kanehara; 2008.
Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.
Kise Y, Kijima H, Shimada H, et al. Gastric tube cancer after esophagectomy for esophageal squamous cell cancer and its relevance to Helicobacter pylori. Hepatogastroenterology. 2003;50:408–11.
Takeo H, Matsukuma S. Gastric tube cancer: immunohistochemical study of 10 lesions in six patients. J Gastroenterol Hepatol. 2007;22:23–9.
Katsoulis IE, Robotis I, Kouraklis G, et al. Duodenogastric reflux after esophagectomy and gastric pull-up: the effect of the route of reconstruction. World J Surg. 2005;29:174–81.
Palmes D, Weilinghoff M, Colombo-Benkmann M, et al. Effect of pyloric drainage procedures on gastric passage and bile reflux after esophagectomy with gastric conduit reconstruction. Langenbecks Arch Surg. 2007;392:135–41.
Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9.
Soetikno RM, Gotoda T, Nakanishi Y, et al. Endoscopic mucosal resection. Gastrointest Endosc. 2003;57:567–79.
Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin N Am. 2000;80:1799–809.
Takeuchi H, Fujii H, Ando N, et al. Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg. 2009;249:757–63.
Takeuchi H, Kawakubo H, Takeda F, et al. Sentinel node navigation surgery in early-stage esophageal cancer. Ann Thorac Cardiovasc Surg. 2012;18:306–13.
Takeuchi H, Kitagawa Y. New sentinel node mapping technologies for early gastric cancer. Ann Surg Oncol. 2013;2:522–32.
Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 2013;31:3704–10.
Hiratsuka M, Miyashiro I, Ishikawa O, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery. 2001;129:335–40.
Uenosono Y, Natsugoe S, Ehi K, et al. Detection of sentinel nodes and micrometastases using radioisotope navigation and immunohistochemistry in patients with gastric cancer. Br J Surg. 2005;92:886–9.
Lee JH, Ryu KW, Kim CG, et al. Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol. 2006;13:1168–74.